Among the family of P2X ATP-gated cation channels, the P2X 7 receptor is a homomeric subtype highly expressed in immune cells of the monocyte-macrophage lineage. We report here that the WC167-168AA mutation in the ectodomain of P2X 7 produced nonfunctional subunits with strong dominant-negative effect on wild-type P2X 7 receptors (77% inhibition with cotransfection of wild-type and mutant DNA at a ratio of 3:1). The C168A single mutant was also very effective in suppressing P2X 7 receptor function (72% reduction at a DNA ratio of 3:1), indicating the major role played by the C168A mutation in this inhibition. The dominant-negative effect is selective; the mutant subunit did not suppress the function of other receptor-channel subtypes. The reduced current responses in cells coexpressing wild-type and dominant-negative subunits display wild-type characteristics in both agonist affinity and ionic selectivity, strongly suggesting that the heteromeric channels are functionally impaired. The mutant subunits also suppressed the P2X 7 -dependent pore formation as assessed by uptake of the propidium dye YO-PRO-1 (Molecular Probes, Eugene, OR) in response to 2Ј,3Ј-O-(4-benzoyl)-benzoyl-ATP (BzATP) in transfected human embryonic kidney 293 cells. Native responses to BzATP as well as ATP-induced ethidium dye uptake were significantly knocked down (31 Ϯ 9% and 25 Ϯ 7% of control, respectively) in mouse macrophage cell line RAW264.7 transfected with the mutant subunits. Therefore, these dominantnegative subunits provide selective genetic tools to investigate the functional roles of native P2X 7 receptors.
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Ionotropic P2X receptors constitute a family of calciumpermeable nonselective cation channels gated by extracellular ATP. Their primary structures define a unique class of multimeric ion channels composed of subunits with two transmembrane domains connected by a large ectodomain. Seven genes coding for P2X channel subunits have been cloned in mammals, and their functional characterization has been described in recombinant systems in homomeric and/or heteromeric forms as well as in native systems (for review, see North, 2002) . The P2X 7 receptor is a homomeric subtype highly expressed in immune cells of the monocytemacrophage lineage, including microglial and dendritic cells . One distinct structural feature of P2X 7 receptor-channels, a large intracellular carboxyl-terminal domain (239 amino acids in mammalian subunits), is involved in the progressive formation of large pores permeable to molecules up to 900 Da (Surprenant et al., 1996; Virginio et al., 1999b) as well as in the efficient release of the proinflammatory cytokine interleukin 1-␤, as demonstrated in a knock-out model (Solle et al., 2001) . In macrophage-related cells and glia, ATP-induced P2X 7 activity has been reported to be linked to a number of cellular events including membrane blebbing and microvesiculation (Virginio et al., 1999a; MacKenzie et al., 2001) , cell fusion (Chiozzi et al., 1997) , activation of nuclear factor-B and nuclear factor of activated T cells (Ferrari et al., , 1999 , activation of p38 mitogenactivated protein kinase (Neary et al., 2003) , activation of phospholipase D elMoatassim and Dubyak, 1993) , killing of intracellular mycobacteria (Lammas et al., 1997; Smith et al., 2001) , and cell death (Di Virgilio et al., 1998) . Although it is not known whether these cellular events depend on specific functional properties of the P2X 7 subtype, they underline the significant role played by P2X 7 receptors in the regulation of immune response in peripheral tissues as well as in the central nervous system. Despite the potential physiological and therapeutic importance of P2X 7 receptors, their pharmacology remains limited. The agonist 2Ј,3Ј-O-(4-benzoyl)-benzoyl-ATP (BzATP) is more potent than ATP at activating rodent and human P2X 7 receptors, and this marked difference in sensitivity has been naturally used as an index of the presence of native P2X 7 receptors. However, their identification cannot be based solely on this differential sensitivity because BzATP has been reported to be an agonist for other P2X receptor subtypes (Bianchi et al., 1999; Boué-Grabot et al., 2000a) . Irreversible blockade of P2X responses by long incubations with oxidized ATP was also considered a solid proof of the involvement of native P2X 7 receptors; however, oxidized ATP has subsequently been shown to block P2X1 and P2X2 receptors (Evans et al., 1995) . A monoclonal antibody directed against an extracellular epitope of P2X 7 subunit has antagonistic properties, but its use is limited to human P2X 7 (Buell et al., 1998) . In search of better antagonists, the dye Brilliant Blue G has been identified as a potent blocker of rat P2X 7 in the 10 to 100 nM range, but it blocks other subtypes in the micromolar range (Jiang et al., 2000a) and its actions on metabotropic ATP receptors have not been tested. The organic cation calmidazolium, a calmodulin antagonist and a blocker of cyclic nucleotide-gated channels (Virginio et al., 1997) , is effective at blocking rat and human P2X 7 receptors but does not block pore formation . Another P2X 7 antagonist, KN-62, a known inhibitor of calcium/calmodulin-dependent protein kinase type II, has little inhibitory effect on the rat P2X 7 (Humphreys et al., 1998) . The lack of unambiguous and cross-species pharmacological tools for P2X 7 prompted us to develop specific sequencebased antagonists. We report here the characterization of dominant-negative mutations located in the ectodomain of P2X 7 subunits that are highly effective at selectively suppressing the function of rodent as well as human P2X 7 receptors. Moreover, we show that these dominant-negative P2X 7 subunits have the property of knocking down the activity of native P2X 7 receptor channels in immune cells.
Materials and Methods
Clones and Mutants. Rat P2X 7 subunit was cloned using reverse transcription-polymerase chain reaction; mouse and human P2X 7 subunits were isolated by screening brain cDNA libraries. Rat P2X 2 and mouse 5HT 3A subunits were kindly provided by D. Julius (University of California, San Francisco). Single and double mutants of mouse P2X 7 were generated using the QuikChange method (Stratagene, La Jolla, CA). The C-terminally tagged versions of wild-type and mutant P2X 7 cDNAs were constructed by removing the stop codons and subcloning a cassette encoding a FLAG epitope, according to previously published protocols (Boué-Grabot et al., 2000b) .
Cell Culture and Transfections. HEK293 cells were cultured as described previously (Le et al., 1998) . HEK293 cells stably expressing the rat P2X 7 subunit (HEK-P2X 7 ), kindly provided by A. Surprenant (University of Sheffield, Sheffield, England), were cultured in Dulbecco's modified Eagle's medium and 10% heat-inactivated fetal bovine serum (Invitrogen, Carlsbad ,CA) containing penicillin and streptomycin supplemented with G-418 (250 g/ml). RAW264.7 cells were kindly provided by M. Desjardins (University of Montreal, PQ, Canada) and were cultured in Dulbecco's modified Eagle's medium and 10% heat-inactivated fetal bovine serum containing 10 mM HEPES buffer (Sigma, St. Louis, MO), 5% L-glutamine (Invitrogen), penicillin, and streptomycin. Cells were transfected with Polyfect (QIAGEN, Valencia, CA) or Fugene 6 (Roche Diagnostics, Indianapolis, IN) according to the manufacturer's protocols. Transfected cells were used for electrophysiological recordings 24 to 48 h after transfection. Oocytes were surgically removed from Tricaine-anesthetized female Xenopus laevis frogs and were incubated with calcium-free Barth's solution containing 1 mg/ml type I collagenase at room temperature for 2 h under vigorous agitation. Stage V and VI oocytes were then manually defolliculated before intranuclear microinjection of 1 to 10 ng of supercoiled plasmid coding for wild-type/mutant mouse P2X 7 , human P2X 7 , rat P2X 7 and P2X 2 , or mouse 5HT 3A . After injection, oocytes were incubated with Barth's solution containing 1.8 mM CaCl 2 at 19°C for 24 to 72 h before electrophysiological recordings.
Electrophysiology. Two-electrode voltage-clamp recordings (V H ϭ Ϫ60 mV) were performed using glass pipettes (1-3 M⍀) filled with 3 M KCl solution. Oocytes were placed in a recording chamber and were perfused at a flow rate of 10 to 12 ml/min with Ringer's solution, pH 7.4, containing 115 mM NaCl, 5 mM NaOH, 2.5 mM KCl, 1.8 mM CaCl 2 , and 10 mM HEPES. Membrane currents (d.c., 1 kHz) were recorded using a Warner OC-725B amplifier (Warner Instrument, Hamden, CT) and digitized at 500 Hz. Drugs were dissolved in the perfusion solution and applied using a computer-driven valve system. Whole-cell patch-clamp recordings (V H of Ϫ60 mV) were performed using pipettes filled with internal solution, pH 7.2, containing 120 mM K-gluconate, 1 mM MgCl 2 , 4 mM NaOH, and 10 mM HEPES. Drugs were applied using a Warner SF-77B fast perfusion system at a rate of 1 ml/min. The perfusion solution, pH 7.4, comprised 145 mM NaCl, 5 mM NaOH, 3 mM KCl, 1 mM MgCl 2 , 0.9 mM CaCl 2 , and 10 mM HEPES. Membrane currents (d.c., 200 Hz) were recorded using an Axopatch 200B amplifier (Axon Instruments Inc., Union City, CA) and digitized at 500 Hz. All drugs were dissolved in the perfusion solution. Current-voltage plots were obtained using a ramp protocol. All experiments were performed at room temperature.
YO-PRO-1 and Ethidium Uptake Imaging. The BzATP-dependent P2X 7 mediated pore formation was assessed by imaging the uptake of YO-PRO-1 (Molecular Probes, Eugene, OR), a 629-Da propidium di-iodide dye that fluoresces when bound to nucleic acids. HEK293 cells were cotransfected with CD8 and wild-type or mutant P2X 7 subunits. Twenty-four hours after transfection, dishes were rinsed twice with perfusion solution and incubated with 2 ϫ 10 7 beads/ml of Dynabeads (Dynal Biotech, Lake Success, NY) for 30 min. After washing, the cells were incubated with perfusion solution containing 1 M YO-PRO-1. BzATP (300 M) was dissolved in low divalent solution, pH 7.4, containing 145 mM NaCl, 5 mM NaOH, 3 mM KCl, 0.09 mM CaCl 2 , and 10 mM HEPES. Fluorescence changes (excitation, 491 nm; emission, 509 nm) were monitored in individual cells rosetted by the beads. RAW264.7 cells were transfected with mutant subunit subcloned in pAdTrack vector containing a GFP expression cassette. After transfection (24 to 48 h), GFP-positive cells were monitored for changes in ethidium fluorescence signals (excitation, 525 nm; emission, 565 nm) in response to application of low divalent solution containing 10 g/ml ethidium bromide in the presence or absence (control) of 3 mM ATP, pH 7.4. The fluorescence signals were corrected for baseline signal levels in control experiments. Images were captured every 30 s on a cooled charge-coupled device camera (Optikon, Kitchener, ON, Canada) and processed using Axon Imaging Workbench 2.2 software (Axon Instruments).
Immunocytochemistry and Confocal Microscopy. Transiently transfected HEK293 cells were fixed with 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in 0.16 M phosphate buffer, pH 6.8. The cells were washed and blocked with 5% normal goat serum (Jackson ImmunoResearch Laboratories Inc., West Grove, PA), 0.3% Triton X-100 (Fisher Scientific, Pittsburgh, PA) in phosphate-buffered saline, pH 7.4, then incubated with anti-FLAG M2 antibody (Sigma) at 4°C overnight. Antibody binding was then revealed using a Texas Red conjugated goat anti mouse (Jack- son ImmunoResearch) for 60 min at room temperature. The confocal fluorescence microscopy images were acquired using an LSM 510 line scanning microscope (Zeiss, Jena, Germany).
Data Analysis. Peak currents, defined as the largest amplitudes recorded during agonist applications, were normalized to the mean of the wild-type currents under each experimental condition. Data are presented as mean Ϯ S.E. The BzATP EC 50 values were calculated by fitting the data to logistical equation using Sigmaplot software (SPSS Inc., Chicago, IL). The proportions of homomeric and heteromeric channels were calculated using binomial distribution. Assuming that heteromeric channels composed of one or more mutant subunits are silent, then the fraction of total current (I/I Total ) is obtained using the binomial equation I/I Total ϭ (1 Ϫ p) n where p is the proportion of mutant subunits and n is the number of subunits in the channel complex. All statistical analyses for the difference in means were carried out using Student's t tests for two unpaired groups. The analysis for the immunofluorescence intensity profiles was carried out using ImageJ software (http://rsb.info.nih.gov/ij).
Results
Mutagenesis and Functional Screening. We reasoned that conserved residues among P2X 7 receptors from different species that are also present in other P2X subtypes may prove critical for their function. We engineered a number of mutant rat P2X 7 subunits and screened them, using twoelectrode voltage-clamp recordings, for their response to Bz-ATP and for their dominant-negative effect when coexpressed with the wild-type subunit in X. laevis oocytes. As summarized in Table 1 and illustrated in Fig. 1 , we observed three phenotypes: 1) functional mutants that produced a current response when expressed alone and did not inhibit the wild-type current when coexpressed (e.g., Y13A ; Fig. 1A) ; 2) nonfunctional mutants that did not inhibit the wild-type current when coexpressed (e.g., DI316-317AA ; Fig. 1B) ; and 3) a nonfunctional mutant that had a dominant-negative effect on wild-type current (WC167-168AA; Fig. 1C ). Because the motif WC167-168 is conserved in all mammalian P2X 7 subunits, we investigated whether the WC167-168AA mutation in mouse P2X 7 subunit has a dominant-negative effect and can block human P2X 7 receptors. We therefore conducted whole-cell voltage-clamp recordings from HEK293 cells transfected with wild-type, mutant, or both at a ratio of 1:1. As shown in Fig. 2 , coexpression of WC167-168AA subunit with wild-type subunits significantly decreased BzATPevoked currents mediated by mouse ( Fig. 2A; 14 Ϯ 2% of wild-type current, n ϭ 10; p Ͻ 0.01) and human P2X 7 receptors ( Fig. 2B ; 23 Ϯ 4% of wild-type current; n ϭ 8, p Ͻ 0.01).
However, the WC167-168AA mutant inhibited neither ATPinduced currents in cells cotransfected with P2X 2 (Fig. 2C ) nor serotonin-evoked currents in cells cotransfected with unrelated 5HT 3A receptor (Fig. 2D) . The WC167-168AA mutation, therefore, has a selective dominant-negative effect on rodent and human P2X 7 receptors.
WC167-168AA Mutant Inhibits YO-PRO-1 Uptake. Activation of P2X 7 receptors results in opening of nonspecific pores permeable to molecules smaller than 900 Da, such as YO-PRO-1 (Surprenant et al., 1996) . We investigated whether the WC167-168AA mutant subunit can block P2X 7 -mediated permeabilization. As shown in Fig. 3, A and B, control cells transfected with the nonfluorescent marker CD8 alone showed no significant increase in YO-PRO-1 uptake in response to BzATP. Cells transfected with wild-type P2X 7 showed a marked time-dependent increase in YO-PRO-1 uptake upon stimulation with BzATP, whereas cells cotransfected with the WC167-168AA mutant and the wild-type subunits (1:1 ratio) exhibited a significantly decreased YO-PRO-1 uptake in response to agonist (12 Ϯ 2% of the P2X 7 transfected cells, 20 min after BzATP application, n ϭ 4).
Impact of WC167-168AA Mutant on Receptor-Channel Properties. To determine whether the expression of the mutant causes a decrease in the agonist sensitivity, we obtained the dose-response curves for BzATP in cells transfected with P2X 7 alone or in the presence of the WC167-168AA mutant (at a 2:1 ratio). As illustrated in Fig. 4A , at any given concentration, the magnitude of current in the cotransfection was smaller than the wild-type. The doseresponses exhibited a sigmoidal relationship with an EC 50 of 538 Ϯ 75 M for the wild-type and 556 Ϯ 31 M for the cotransfection (n ϭ 4) (Fig. 4B) . To investigate whether the coexpression of the mutant subunit changed the ionic selectivity of P2X 7 receptor-channels, we plotted the current-voltage (I-V) relationship for BzATP-evoked currents in cells transfected with wild-type subunit alone or cotransfected with the WC167-168AA subunit. In both cases, I-V relationship displayed a linear slope between Ϫ70 and ϩ30 mV. Moreover, as shown in Fig. 4C , the reversal potential of BzATP-evoked currents in cells transfected with wild-type alone was not significantly different from that obtained in cells cotransfected with the WC167-168AA subunit (1.3 Ϯ 2.6 mV versus Ϫ1.3 Ϯ 1.7 mV; respectively, n ϭ 5). These results indicate that the WC167-168AA mutant does not inhibit P2X 7 receptor-channels function by reducing agonist Single and double mutations in rat P2X 7 subunit were designed to target residues conserved in the mammalian P2X family. The mutant receptors were assayed for their response to 50 M BzATP. The dominant-negative (Dn) effect of the mutant subunits was determined at a 2:1 ratio with the wild-type subunit. measuring the fluorescence intensity along a line randomly drawn through the diameter of the cell, were identical for both the wild-type and mutant subunits (Fig. 5, A-C) . The staining for wild-type and mutant P2X 7 subunits was most intense at the edges of the cell, in contrast to the cytoplasmic Fig. 1 . Representative phenotypes of mutant P2X7 subunits. A, a functional mutant (Y13A) giving a weaker response to BzATP without any inhibitory effects on wild-type P2X 7 receptors. B, a silent mutant (DI318 -319AA) with no inhibitory effect on wild-type P2X 7 receptors. C, the WC167-168AA mutant is silent and exhibits a dominant-negative effect on wild-type P2X 7 receptors (20 Ϯ 5% of wild-type current, n ϭ 5, p Ͻ 0.01). Voltage-clamp recordings were carried out in Xenopus oocytes. Wild-type to mutant cDNA ratio was 1:2. Fig. 2 . Dominant-negative mutant subunits selectively suppress P2X 7 channel activity. A and B, at a 1:1 ratio, mouse WC167-168AA P2X 7 subunit (Dn) strongly suppressed BzATP-induced responses mediated by both wild-type mouse (14 Ϯ 2% of control, p Ͻ 0.01, A) and human P2X 7 receptors (23 Ϯ 4% of control, p Ͻ 0.01, B). C and D. The mutant did not interfere with the function of P2X 2 or unrelated 5HT 3A receptors when coexpressed. Wild-type to mutant cDNA ratio was 1:1. Fig. 3 . Suppression of YO-PRO-1 uptake by dominant-negative subunits. A, time-dependent increase in fluorescence intensity in response to application of 300 M BzATP in low divalent extracellular solution is shown. HEK293 cells were transfected with wild-type P2X 7 subunits or cotransfected with WC167-168AA and wild-type P2X 7 subunits (P2X 7 ϩ Dn) or transfected with CD8 only. Agonist was applied at time 300 s. B. The average YO-PRO-1 fluorescence intensities in the presence (ϩ) or absence (Ϫ) of BzATP stimulation. The YO-PRO-1 uptake in cells coexpressing the wild-type and mutant subunits is lower than in cells expressing wild-type subunit alone (89 Ϯ 17 versus 736 Ϯ 225 arbitrary units, n ϭ 4, p Ͻ 0.01).
Fig. 4.
Receptor-channel properties in cells coexpressing wild-type and WC167-168AA subunits A. Representative recordings of whole cell P2X 7 currents at different concentrations of BzATP in HEK293 cells expressing wild-type P2X 7 alone or in combination with WC167-168AA subunit (Dn) at a 2:1 ratio. Note the suppression of current at all concentrations of BzATP tested. B, no significant decrease in the EC 50 values for BzATP between P2X 7 and (P2X 7 ϩ Dn) currents. C, current-voltage relationship for BzATP currents in cells expressing P2X 7 alone or with Dn. The slope conductance is linear at holding potentials between Ϫ70 and ϩ30 mV. No significant change in the current reversal potential was observed in the presence of Dn (ϩ1.3 Ϯ 2.6 versus Ϫ1.3 Ϯ 1.7 mV for wild-type alone, n ϭ 4).
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at ASPET Journals on June 21, 2017 molpharm.aspetjournals.org distribution of EGFP in the same cell (Fig. 5D) . These results show that most wild-type and mutant subunits are transported to the plasma membrane, hence indicating that the functional knock-down of P2X7 receptor is not caused by disturbed trafficking or intracellular retention.
Potency of Inhibitory WC167-168AA and C168A Mutants. To determine the potency of the inhibitory effect of the WC167-168AA subunits on P2X 7 receptors, HEK293 cells were transfected with a fixed concentration of wild-type cDNA and varying concentrations of the mutant. As illustrated in Fig. 6A , the amplitude of the current is greatly reduced (74 Ϯ 6%) by cotransfecting wild type with mutant subunits at a ratio as low as 2:1. The amplitude of BzATPevoked currents decreased with increasing proportions of the mutant subunit, as expected for a dominant-negative effect ( Fig. 6C and Table 2 ).
Next, we sought to determine the key residue involved in the inhibitory effect of the WC167-168AA subunit. We investigated the effects of single W167A and C168A mutations on the function of the P2X 7 receptor. The W167A mutant was nonfunctional when expressed alone, with no obvious dominant-negative effects (data not shown). The C168A mutant, on the other hand, exhibited a substantial inhibitory effect as shown in Fig. 6B (80 Ϯ 5% at 2:1 ratio). The dominantnegative effect increased exponentially with increasing proportions of mutant subunit (Fig. 6C and Table 2 ). These data indicate that the WC167-168AA and C168A mutants are highly effective inhibitory subunits for P2X 7 receptors.
Knock-Down of Native P2X 7 Function by DominantNegative Mutants. In the previous experiments, we assessed the knock-down of wild-type receptors transiently coexpressed with the mutant subunits in heterologous systems. However, in cells natively expressing P2X 7 receptors, there is a pre-existing pool of surface receptors. So, as a first step to test the sensitivity of endogenous P2X 7 receptors to dominant-negative blockade, we investigated the effect of the expression of the mutant subunits in HEK293 cells stably expressing P2X 7 receptors (HEK-P2X 7 ) at a high level (Surprenant et al., 1996) . In HEK-P2X 7 cells, transient expression of the WC167-168AA mutant subunits resulted in a significant reduction of the current responses to BzATP (15 Ϯ 5% of control, p Ͻ 0.05, n ϭ 3, Fig. 7A ). Next, we tested the effects of expression of the dominant-negative subunits in mouse macrophage cell line RAW264.7. As shown in Fig. 7B , the dominant-negative C168A subunit significantly reduced the endogenous current responses to BzATP (31 Ϯ 9% of control, p Ͻ 0.05, n ϭ 3, Fig. 7B ). Pore formation measured by the uptake of ethidium ions in response to application of agonist was also knocked down by transient expression of the C168A mutant subunit (25 Ϯ 7% of control, p Ͻ 0.01, Fig. 8 ).
These results indicate that the C168A dominant-negative subunits are able to effectively suppress both the current response and pore formation mediated by native P2X 7 receptors in immune cells.
Discussion
In an effort to design pan-specific and subtype-selective inhibitors of mammalian P2X 7 ATP receptors, we searched for mutations with dominant-negative effect. The functional screening based on electrophysiological recordings led to the identification of one mutation with the required properties. The inhibitory P2X 7 subunit with double mutation WC167-168AA located in the ectodomain assembles into nonfunctional homomeric channels. Neither Trp167 nor Cys168, which are conserved in the whole P2X family, has been reported to be a determinant of the ATP-binding site (Jiang et al., 2000b) . However, because of the presence of disulfide bridges in the ectodomain (Clyne et al., 2002; Ennion and Evans, 2002) , the role of different extracellular regions in receptor function remains difficult to assess in the absence of crystallographic data. Nevertheless, we can conclude from this screening that the conserved P2X motif WC167-168 is not involved in subunit association. In our screen, the other nonfunctional subunits with mutations in the ectodomain displayed no inhibitory activity, suggesting either that they were degraded prematurely because of misfolding or that they did not associate correctly with the wild-type subunits.
Mammalian P2X 7 subunits share significant homology (e.g., 80% between mouse and human), so we hypothesized that they would be able to associate into hybrid receptorchannels. We confirmed the coassembly of mouse and human P2X 7 subunits by knocking down human P2X 7 receptor function with mouse WC167-168AA mutant subunits (Fig. 2) . The logical consequence of this compatibility of association is that dominant-negative P2X 7 subunits from one species are able to suppress the function of P2X 7 receptors in other species. Therefore, this genetic approach based on the expression of mutant subunits provides an advantage over knockout strategies, which are currently limited to mice. Potentially, a gene therapy approach leading to the overexpression of dominant-negative P2X 7 subunits and the knockdown of human macrophage or microglial P2X 7 responses could be beneficial in the control of inflammatory diseases (Cucchiarini et al., 2003) .
Phylogenetically and functionally, vertebrate P2X 7 subunits define a distinct gene subfamily (North, 2002) . Indeed all P2X subunits have been shown to associate in heteromeric receptors (Khakh et al., 2001) , except P2X 7 subunits, which seem to form homomers exclusively (Torres et al., 1999) . This unique property of P2X 7 subunits provides a methodological advantage to selectively target the P2X 7 receptors while sparing all other coexpressed P2X subtypes. By coexpressing the mutant P2X 7 subunits with P2X 2 subunits, we demonstrated the subtype selectivity and we confirmed the absence of heteromeric P2X 2ϩ7 ATP receptors. Likewise, the mutant P2X 7 subunit did not suppress the function of unrelated homomeric 5HT 3A receptor channels, chosen here as a prototypical member of the Cys-loop family of transmitter-gated channels. So, the WC167-168AA mutation conferred strong and specific dominant-negative effect to the subunit for the rodent and human P2X 7 subtypes of ionotropic ATP receptors.
Several members of the P2X receptor family, including P2X 7 , are capable of forming large pores in response to agonist stimulation. The exact function of these pores is not known; however; given their ability to provide passage for molecules such as L-glutamate (Ballerini et al., 1996; Duan et al., 2003) , they potentially play a crucial role in cell signaling and metabolism. The mechanisms linking channel activity and pore formation are not well understood. Calmidazolium has been shown to distinguish between the pore and channel states of P2X 7 receptors because it can block the channel without affecting the pore formation (Virginio et al., 1997) . This suggests that the pore-forming activity of P2X 7 receptors may not require the opening of the channel. Given that other members of the P2X receptor family have been shown to promote pore formation (Khakh et al., 1999; .,   TABLE 2 The effect of co-expression of mutant and wild type subunits on current amplitude
The percentage of predicted total currents was calculated based on the binomial distribution of homomeric and heteromeric populations of channels in co-expression experiments. Incorporation of one mutant subunit was assumed to be sufficient to knock down the channel function. 1999b), an effective tool for the study of P2X 7 receptors should also be able to block this function. Our YO-PRO-1 and ethidium uptake data demonstrate that the knock-down by the dominant-negative subunits is complete in that it suppresses both the channel-and the pore-forming functions of recombinant and native P2X 7 receptors. Two mechanisms by which a dominant-negative subunit is likely to exert its inhibitory effect are either by binding and sequestering the agonist away from the receptor (sink effect) or by directly associating with the receptor and blocking its function. It seems unlikely that the dominant-negative subunits described here act via a sink effect because 1) mutation of the conserved cysteines in the ectodomain of other P2X receptors has been shown to reduce the sensitivity of the receptor to ATP (Clyne et al., 2002; Ennion and Evans, 2002) and 2) the dominant-negative subunits are highly effective at blocking the wild-type receptors at low proportions. Our data show that the reduced current response has wild-type characteristics in both agonist affinity and reversal potential, indicating that channels composed of dominant-negative and wild-type subunits are silent. Hence, the dominant-negative subunits probably block the function of P2X 7 receptors by association, which leads to a reduction in the number of homomeric wild-type channels.
The immunolocalization of wild-type and mutant P2X 7 subunits in transfected cells and the corresponding subcellular distribution profiles show that the translocation of the dominant-negative P2X 7 subunits to the plasma membrane is as efficient as the one of wild-type P2X 7 subunits. We can conclude from these results that the WC167-168AA or the C168A mutant subunits do not knock-down P2X 7 receptor function by intracellular retention or degradation of wildtype subunits. Heteromeric nonfunctional P2X 7 receptors composed of wild-type and mutant subunits are translocated to the plasma membrane, so it confirms that the inhibition of P2X 7 activity is probably caused by a decrease in the number of homomeric wild-type channels available at the cell surface.
There are 10 conserved cysteines in the ectodomain of P2X receptor family that form disulfide bonds and are important for the correct folding of the ATP binding domain (Clyne et al., 2002) . Interestingly, the single mutation C168A was able to mimic the dominant-negative properties of the double mutation WC167-168AA, demonstrating the major contribution of this extracellular cysteine residue to the inhibitory effect and its importance in the normal function of P2X 7 receptors. Although not silent, the rat P2X 2 C164A and human P2X 1 C165A mutant receptors have been shown to be deficient in trafficking to the surface (Clyne et al., 2002; Ennion and Evans, 2002) . According to our immunolocalization data, substitution of Cys168 with alanine in P2X 7 did not lead to disturbed trafficking of the receptors. However, the loss of a disulfide bridge could explain the inhibitory effect of the mutation through a major conformational change in the In cells coexpressing the wild-type and the mutant subunits, the relative proportion of functional homomeric wildtype, silent homomeric mutant, and silent or functionally impaired heteromeric P2X 7 receptors follows a statistical distribution that depends on the ratio of the subunits, on the affinity of the intersubunit associations, and on the number of subunits in the ion channel. If the affinity for intersubunit association is similar between mutant and wild-type subunits and one single subunit is necessary and sufficient to block a P2X 7 channel, the binomial distribution of the different populations of receptors would translate into an exponential decrease in P2X 7 current with increasing proportions of mutant subunits (Table 2) .
Indeed, the experimental dose-response curves for the dominant-negative effects are clearly exponential and are compatible with a trimeric or tetrameric configuration of P2X 7 receptors (Table 2) . These data support a model in which one dominant-negative subunit is sufficient to knock down the function of the channel. Therefore, it provides further evidence that the inhibitory effect of these dominantnegative subunits is not merely an effect of dilution of functional subunits. P2X channels are believed to have a trimeric architecture (Nicke et al., 1998) , so in native preparations, the cotranslation of only one dominant-negative mutant subunit with two wild-type endogenous subunits might generate a significant knock-down of P2X 7 responses (Table 2) .
When we tested the effectiveness of the dominant-negative mutant P2X 7 subunits on a pre-existing pool of P2X 7 receptors in a HEK293 stable cell line, we recorded a significant reduction of BzATP-induced P2X 7 currents. As a proof-ofconcept validating this selective dominant-negative approach, transient expression of mutant subunits in natively P2X 7 -expressing RAW264.7 cells also led to a significant knock-down of endogenous P2X 7 receptor function. However, we noticed that in both cases, the decrease of current was lower than that observed in our cotransfection experiments. The simplest interpretation of this apparently lower inhibition in native preparations would be that the amount of cotranslation of mutant subunits with de novo wild-type P2X 7 subunits is limited by the short time window of transient expression. The turnover rate of P2X 7 receptors in RAW264.7 cells is not known, but half-lives as long as 10 days have been reported for other ionotropic receptors (Wang et al., 1999) . Longer-term coexpression of mutant subunits with endogenous P2X 7 subunits is likely to improve the effectiveness of this dominant-negative approach in macrophage-related cell types. Because these cell types are notoriously resistant to transfection (Burke et al., 2002) , transgenic or viral expression of dominant-negative WC167-168AA or C168A mutant P2X 7 subunits would provide more effective approaches to knock down native P2X 7 responses in peripheral macrophages and in microglia.
In conclusion, dominant-negative P2X 7 subunits can be used to selectively suppress the channel activity of P2X 7 receptors and the associated pore formation without interfering with a wide variety of other conductances sensitive to extracellular ATP. Thus, they provide novel genetic tools to investigate the physiological and pathological role of native PX 7 receptors in inflammation and in immune response.
